Suppr超能文献

从巴基斯坦卡拉奇尿路感染患者尿液样本中分离出的铜绿假单胞菌的抗生素耐药模式。

Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from urine samples of Urinary Tract Infections patients in Karachi, Pakistan.

作者信息

Shah Dania Aijaz, Wasim Shehnaz, Essa Abdullah Farhan

机构信息

Dania Aijaz Shah, Dow University of Health Sciences, Baba-E-Urdu Road, Karachi 74200, Pakistan.

Shehnaz Wasim, Ziauddin University, 4/B, Shahrah-e-Ghalib, Block 6, Clifton, Karachi - 75600, Pakistan.

出版信息

Pak J Med Sci. 2015 Mar-Apr;31(2):341-5. doi: 10.12669/pjms.312.6839.

Abstract

OBJECTIVE

The aim of this study was to evaluate the antibiotic resistance pattern of Psedomonas aeruginosa and its prevalence in patients with urinary tract infections (UTI) for effective treatment in a developing country like Pakistan.

METHODS

This is an observational study conducted for a period of ten months which ended on December 2013 at the Dr. Essa Laboratory and Diagnostic Centre in Karachi. A total of 4668 urine samples of UTI patients were collected and standard microbiological techniques were performed to identify the organisms in urine cultures. Antibiotic susceptibility testing was performed by Kirby-Bauer technique for twenty five commonly used antimicrobials and then analyzed on SPSS version 17.

RESULTS

P. aeruginosa was isolated in 254 cultures (5.4%). The most resistant drugs included Ceclor(100%) and Cefizox (100%) followed by Amoxil/Ampicillin (99.6%), Ceflixime (99.6%), Doxycycline (99.6%), Cefuroxime (99.2%), Cephradine (99.2%), Cotrimoxazole (99.2%), Nalidixic acid (98.8%), Pipemidic acid (98.6%) and Augmentin (97.6%).

CONCLUSION

Emerging resistant strains of Pseudomonas aeruginosa are potentially linked to injudicious use of drugs leading to ineffective empirical therapy and in turn, appearance of even more resistant strains of the bacterium. Therefore, we recommend culture and sensitivity testing to determine the presence of P.aeruginosa prior to specific antimicrobial therapy.

摘要

目的

本研究旨在评估铜绿假单胞菌的抗生素耐药模式及其在尿路感染(UTI)患者中的流行情况,以便在巴基斯坦这样的发展中国家进行有效治疗。

方法

这是一项为期十个月的观察性研究,于2013年12月在卡拉奇的埃萨博士实验室和诊断中心结束。共收集了4668份UTI患者的尿液样本,并采用标准微生物技术对尿培养中的微生物进行鉴定。通过 Kirby-Bauer 技术对25种常用抗菌药物进行抗生素敏感性测试,然后在SPSS 17版上进行分析。

结果

在254份培养物中分离出铜绿假单胞菌(5.4%)。耐药性最强的药物包括头孢克洛(100%)和头孢唑肟(100%),其次是阿莫西林/氨苄西林(99.6%)、头孢克肟(99.6%)、强力霉素(99.6%)、头孢呋辛(99.2%)、头孢拉定(99.2%)、复方新诺明(99.2%)、萘啶酸(98.8%)、吡哌酸(98.6%)和阿莫西林克拉维酸钾(97.6%)。

结论

新出现的铜绿假单胞菌耐药菌株可能与药物使用不当有关,导致经验性治疗无效,进而出现更多耐药菌株。因此,我们建议在进行特定抗菌治疗之前进行培养和药敏试验,以确定是否存在铜绿假单胞菌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f6f/4476338/33bd040fc258/PJMS-31-341-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验